Maxim Group initiated coverage on Assertio Therapeutics with a new price target

7/26/24 7:49:44 AM ET

Biotechnology: Pharmaceutical Preparations

Health Care

Maxim Group initiated coverage of Assertio Therapeutics with a rating of Buy and set a new price target of $3.00

Save time and jump to the most important pieces.

Recent Analyst Ratings for
$ASRT

Date	Price Target	Rating	Analyst
7/26/2024	$3.00	Buy	Maxim Group
7/3/2024	$4.00	Buy	H.C. Wainwright
11/7/2022	$7.00	Buy	Lake Street